176 related articles for article (PubMed ID: 6193689)
1. Studies on the in vivo synthesis of methotrexate polyglutamates and their efflux properties in normal, proliferative, and neoplastic mouse tissues.
Poser RG; Sirotnak FM
Adv Exp Med Biol; 1983; 163():259-74. PubMed ID: 6193689
[TBL] [Abstract][Full Text] [Related]
2. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo.
Poser RG; Sirotnak FM; Chello PL
Cancer Res; 1981 Nov; 41(11 Pt 1):4441-6. PubMed ID: 6171339
[TBL] [Abstract][Full Text] [Related]
3. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse.
Samuels LL; Goutas LJ; Priest DG; Piper JR; Sirotnak FM
Cancer Res; 1986 May; 46(5):2230-5. PubMed ID: 2421872
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytes.
Fry DW; Gewirtz DA; Yalowich JC; Goldman ID
Adv Exp Med Biol; 1983; 163():215-34. PubMed ID: 6193686
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
Whitehead VM
Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of the intracellular levels of polyglutamyl derivatives of methotrexate by vincristine and probenecid in Ehrlich ascites tumor cells.
Fry DW; Yalowich JC; Goldman ID
Cancer Res; 1982 Jul; 42(7):2532-6. PubMed ID: 6177396
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and retention of methotrexate polyglutamates in Ehrlich ascites carcinoma cells.
Balińska M
Drugs Exp Clin Res; 1986; 12(6-7):551-4. PubMed ID: 2427298
[TBL] [Abstract][Full Text] [Related]
8. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.
Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID
Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870
[TBL] [Abstract][Full Text] [Related]
9. Facilitated transport of methotrexate polyglutamates into lysosomes derived from S180 cells. Further characterization and evidence for a simple mobile carrier system with broad specificity for homo- or heteropeptides bearing a C-terminal glutamyl moiety.
Barrueco JR; O'Leary DF; Sirotnak FM
J Biol Chem; 1992 Oct; 267(28):19986-91. PubMed ID: 1383199
[TBL] [Abstract][Full Text] [Related]
10. Insulin effects on methotrexate polyglutamate synthesis and enzyme binding in cultured human breast cancer cells.
Schilsky RL; Ordway FS
Cancer Chemother Pharmacol; 1985; 15(3):272-7. PubMed ID: 2414022
[TBL] [Abstract][Full Text] [Related]
11. Retentiveness of methotrexate polyglutamates in cultured L1210 cells. Evidence against a role for mediated plasma membrane transport outward.
Schlemmer SR; Sirotnak FM
Biochem Pharmacol; 1993 Mar; 45(6):1261-6. PubMed ID: 7682074
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells.
Jolivet J; Schilsky RL; Bailey BD; Drake JC; Chabner BA
J Clin Invest; 1982 Aug; 70(2):351-60. PubMed ID: 6178756
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, binding and intracellular retention of methotrexate polyglutamates by cultured human breast cancer cells.
Schilsky RL; Jolivet J; Bailey BD; Chabner BA
Adv Exp Med Biol; 1983; 163():247-57. PubMed ID: 6193688
[TBL] [Abstract][Full Text] [Related]
14. Proliferation-dependent cytotoxicity of methotrexate in murine L5178Y leukemia.
Fernandes DJ; Sur P; Kute TE; Capizzi RL
Cancer Res; 1988 Oct; 48(20):5638-44. PubMed ID: 2458828
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate polyglutamate synthesis by cultured human breast cancer cells.
Schilsky RL; Bailey BD; Chabner BA
Proc Natl Acad Sci U S A; 1980 May; 77(5):2919-22. PubMed ID: 6156458
[TBL] [Abstract][Full Text] [Related]
16. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell.
Seither RL; Rape TJ; Goldman ID
Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676
[TBL] [Abstract][Full Text] [Related]
17. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
18. Role of polyglutamates in methotrexate action.
Wilmanns W; Schalhorn A
Chemioterapia; 1985 Oct; 4(5):349-53. PubMed ID: 2416481
[TBL] [Abstract][Full Text] [Related]
19. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
[TBL] [Abstract][Full Text] [Related]
20. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
Jolivet J; Chabner BA
J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
